Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2021
January 29, 2021 at 11:40 am IST
Share
Japan Lifeline Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2021. For the year, the company expects net sales of JPY 51,787 million, operating profit of JPY 10,438 million and profit attributable to owners of parent of JPY 2,286 million or JPY 28.47 per share.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
